News
ASML's unrivaled EUV monopoly is a technological marvel, secured by deep innovation and impossible-to-replicate ...
Achieve Life Sciences offers a compelling risk/reward profile with its promising smoking cessation therapy, cytisinicline.
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...
(KRON) — The future of one biotech company on the Peninsula is drastically changing. Unity Biotechnology is laying off its entire workforce, the company announced Monday in a press release.
Unity Biotechnology, a Bay Area company that once won high-profile backers and a $700 million valuation for its research into aging, is now laying off every one of its remaining employees.
The company expects to lay off the majority of its workforce by the end of the second fiscal quarter, according to SEC filings. Mural Oncology is a biotechnology company that focuses on using its ...
After San Francisco biotech company Third Harmonic Bio slashed its staff by half in February, it’s now taking a more drastic step. The inflammatory disease research company’s directors have ...
The U.S.-based biotechnology company is also known for its ambitious goal of bringing back the extinct woolly mammoth by 2028. This dire wolf pup is among the first of its species born in around ...
The staff reductions are slated to occur on May 27. — Roche Molecular Systems, a unit of pharmaceutical company Roche, 108 job cuts in Santa Clara. The layoffs are scheduled for May 28.
Biotech companies are innovators, which could translate into growth for your portfolio. It’s important to think long term and pay particular attention to a biotech’s pipeline -- today’s out ...
The Japanese pharmaceutical company Taiho Pharmaceutical is set to acquire the Swiss antibody-drug conjugate (ADC) company Araris Biotech for $400 million. Taiho and Araris have been collaborating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results